ArticleFrontiers in oncology2020

Effect of β-Blocker in Treatment-Naïve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs.

Chia-Hao Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.